Remission from HIV-1 infection: discovery of broadly neutralizing antibodies that contribute to virus control
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for ...
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for ...
ROCHESTER, Minn. ¾ A Mayo Clinic study published in Journal of Translational Medicine evaluated the use of genomic testing broadly ...
The rapid evolution and emergence of new SARS-CoV-2 variants, such as the Omicron variant, renders it highly capable of evading ...
Each year in the U.S., 5,000 patients receive a diagnosis of ALS, an incurable neurodegenerative disease that will likely kill ...
A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new ...
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised ...
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper ...
Twitter sentiment around vaping went from broadly positive to mostly negative during the pandemic, probably because of risks of vaping ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.